Oclacitinib therapy in two cats with refractory proliferative and necrotising otitis externa
Veterinary Dermatology · 2024
DOI: 10.1111/vde.13269 ↗Kurz gefasst
Fallbericht in der Zeitschrift Veterinary Dermatology, 2024. Verfasst von Tim Chan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cummings School of Veterinary Medicine at Tufts University, North Grafton, Massachusetts, USA. Hauptthemen laut MEDLINE: Cat Diseases, Otitis Externa. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Feline proliferative and necrotising otitis externa (PNOE) is a rare immune‐mediated condition, usually self‐limiting or responsive to immunosuppressants such as topical tacrolimus. This case report describes two cats with refractory PNOE that responded successfully to oclacitinib. One cat also had middle ear involvement and the other cat had extra‐auricular dermatitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cummings School of Veterinary Medicine at Tufts University, North Grafton, Massachusetts, USA.
- Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, Saint Paul, Minnesota, USA.
ORCID-Profile: Tim Chan, Sandra Nogueira Koch, Ekaterina Mendoza-Kuznetsova
Zitieren
APA
Chan, T., Koch, S. N., Devine, S., & Mendoza-Kuznetsova, E. (2024). Oclacitinib therapy in two cats with refractory proliferative and necrotising otitis externa. Veterinary Dermatology. https://doi.org/10.1111/vde.13269
Vancouver
Chan T, Koch SN, Devine S, Mendoza-Kuznetsova E. Oclacitinib therapy in two cats with refractory proliferative and necrotising otitis externa. Veterinary Dermatology. 2024. doi:10.1111/vde.13269
BibTeX
@article{Chan2024,
author = {Chan, Tim and Koch, Sandra Nogueira and Devine, Samuel and Mendoza-Kuznetsova, Ekaterina},
title = {Oclacitinib therapy in two cats with refractory proliferative and necrotising otitis externa},
journal = {Veterinary Dermatology},
year = {2024},
doi = {10.1111/vde.13269}
}
EUVIMED